AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 200256 — intervention group
Group type: EXPERIMENTAL
Intervention: graduated doses of mestranol up to 50 microgram
Number of subjects: 50
Study 200256 — intervention group
Group type: EXPERIMENTAL
Intervention: conjugated equine oestrogen (1.25 mg daily)
Number of subjects: 50
Study 200256 — intervention group
Group type: EXPERIMENTAL
Intervention: oestrogen valerate (2 mg daily)
Number of subjects: 50
Study 30832370 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor high temperature (28 °C, 32 °C, 36 °C, 38 °C)
Number of subjects: 10
Study 30832370 — intervention group
Group type: EXPERIMENTAL
Intervention: Forehead temperature
Number of subjects: 10
Study 28274907 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Device-Based Electronic Data Capture (mEDC) system
Number of subjects: 1333
Study 25951506 — intervention group
Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil (oral administration); doses of 37.5, 50, and 62.5 mg dosed every 8, 12, and 24 hours.
Number of subjects: 0
Study 25951506 — intervention group
Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil (intravenous administration); pharmacokinetics described by a linear 2-compartment model.
Number of subjects: 0
Study 25951506 — intervention group
Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil; pharmacodynamic effect.
Number of subjects: 0
Study 23442899 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitor monotherapy
Number of subjects: 4041
Study 23442899 — intervention group
Group type: COMPARATOR
Intervention: Baseline presence of suicidal ideation (SI)
Number of subjects: 4041
Study 22043675 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm needling therapy
Number of subjects: 60
Study 22043675 — intervention group
Group type: COMPARATOR
Intervention: Seretide inhalant
Number of subjects: 60
Study 22043675 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 60
Study 19735957 — intervention group
Group type: EXPERIMENTAL
Intervention: Jelly containing 5 g sc-FOS and 0.3 g Sideritis euboea extract
Number of subjects: 64
Study 19735957 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 16500173 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (RX) for 6 months including total body RX and isolated lumbar extension exercise
Number of subjects: 84
Study 16500173 — intervention group
Group type: COMPARATOR
Intervention: Nonexercising group (Control)
Number of subjects: 84
Study 15727147 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (0.2 g orally once a day)
Number of subjects: 88
Study 15727147 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole (0.2 g orally twice a day)
Number of subjects: 88
Study 15727147 — intervention group
Group type: COMPARATOR
Intervention: Ketoconazole (0.2 g orally twice a day)
Number of subjects: 88
Study 11330886 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering (mean DBP < or = 90 mmHg)
Number of subjects: 18790
Study 11330886 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering
Number of subjects: 18790
Study 9217621 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg per day
Number of subjects: 47
Study 9217621 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 8131440 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide
Number of subjects: 40
Study 8131440 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 40
Study 3520796 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine, 150 mg three times a day
Number of subjects: 41
Study 3520796 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 31646393 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional 1064-nm Nd:YAG picosecond laser
Number of subjects: 30
Study 31646393 — intervention group
Group type: COMPARATOR
Intervention: Fractional 1550-nm erbium fiber laser
Number of subjects: 30
Study 28258747 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy with somatosensory stimulation
Number of subjects: 67
Study 28258747 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 67
Study 26964995 — intervention group
Group type: EXPERIMENTAL
Intervention: Elisidepsin (10 mg flat dose, Arm A)
Number of subjects: 44
Study 26964995 — intervention group
Group type: EXPERIMENTAL
Intervention: Elisidepsin (3.75 mg flat dose, Arm B)
Number of subjects: 44
Study 23877137 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-framing with scripted parental mediation
Number of subjects: 320
Study 23877137 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-framing
Number of subjects: 320
Study 23877137 — intervention group
Group type: EXPERIMENTAL
Intervention: Unscripted parental mediation
Number of subjects: 320
Study 23877137 — intervention group
Group type: EXPERIMENTAL
Intervention: Scripted parental mediation
Number of subjects: 320
Study 23877137 — intervention group
Group type: COMPARATOR
Intervention: Control (no mediation)
Number of subjects: 320
Study 23494199 — intervention group
Group type: EXPERIMENTAL
Intervention: Tao Brush endometrial sampling on day 8-9 of the uterine cycle preceding stimulation (Group 2)
Number of subjects: 150
Study 23494199 — intervention group
Group type: EXPERIMENTAL
Intervention: Tao Brush endometrial sampling on day 8-9 of the same IUI cycle (Group 3)
Number of subjects: 150
Study 23494199 — intervention group
Group type: COMPARATOR
Intervention: IUI with no endometrial sampling (Group 1)
Number of subjects: 150
Study 20229132 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions from medical care providers
Number of subjects: 3556
Study 20229132 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention services from health educators, social workers, or paraprofessional HIV-infected peers
Number of subjects: 3556
Study 20229132 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 3556
Study 18954461 — intervention group
Group type: EXPERIMENTAL
Intervention: AR7 Joint Complex (1 capsule daily for 12 weeks)
Number of subjects: 100
Study 18954461 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 capsule daily for 12 weeks)
Number of subjects: 100
Study 18954461 — intervention group
Group type: EXPERIMENTAL
Intervention: AR7 Joint Complex
Number of subjects: 100
Study 18954461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 16842549 — intervention group
Group type: EXPERIMENTAL
Intervention: Coated pH 5.5 latex gloves
Number of subjects: 20
Study 16842549 — intervention group
Group type: COMPARATOR
Intervention: Standard powder-free latex gloves
Number of subjects: 20
Study 12523884 — intervention group
Group type: EXPERIMENTAL
Intervention: argon laser trabeculoplasty plus topical betaxolol
Number of subjects: 255
Study 12523884 — intervention group
Group type: COMPARATOR
Intervention: no immediate treatment
Number of subjects: 255
Study 12523884 — intervention group
Group type: EXPERIMENTAL
Intervention: IOP reduction from baseline to the first follow‐up visit
Number of subjects: 255
Study 12523884 — intervention group
Group type: EXPERIMENTAL
Intervention: first IOP at 3 months' follow‐up
Number of subjects: 255
Study 12523884 — intervention group
Group type: EXPERIMENTAL
Intervention: mean IOP at follow‐up
Number of subjects: 255
Study 12523884 — intervention group
Group type: EXPERIMENTAL
Intervention: percent of patient follow‐up visits with disc hemorrhages
Number of subjects: 255
Study 10351929 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of dry powder mannitol (approximately 300 mg)
Number of subjects: 11
Study 10351929 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline breathing maneuvers without mannitol)
Number of subjects: 11
Study 10351929 — intervention group
Group type: COMPARATOR
Intervention: Baseline (no intervention)
Number of subjects: 11
Study 9015926 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen method for gastric emptying of liquid food
Number of subjects: 8
Study 9015926 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotope method for gastric emptying of solid food
Number of subjects: 8
Study 9015926 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with serum acetaminophen concentration (45 min value)
Number of subjects: 8
Study 9015926 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with % gastric retention of isotope (120 min value)
Number of subjects: 8
Study 10147001 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine
Number of subjects: 0
Study 10147001 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2860913 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 0
Study 2860913 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium (larger doses)
Number of subjects: 0
Study 2860913 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium
Number of subjects: 0
Study 2860913 — intervention group
Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 0
Study 31922272 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial Shaving combined with Photodynamic Therapy (SS‐PDT)
Number of subjects: 72
Study 31922272 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 72
Study 29370788 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose radial extracorporeal shock wave therapy (rESWT)
Number of subjects: 25
Study 29370788 — intervention group
Group type: COMPARATOR
Intervention: Local corticosteroid injection (LCsI)
Number of subjects: 25
Study 26848262 — intervention group
Group type: EXPERIMENTAL
Intervention: Umeclidinium/vilanterol (UMEC/VI)
Number of subjects: 0
Study 26848262 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium (TIO)
Number of subjects: 0
Study 24902921 — intervention group
Group type: EXPERIMENTAL
Intervention: Active elastic compression stockings
Number of subjects: 100
Study 24902921 — intervention group
Group type: COMPARATOR
Intervention: Placebo elastic compression stockings
Number of subjects: 100
Study 22632385 — intervention group
Group type: EXPERIMENTAL
Intervention: MI + CBT (n = 9)
Number of subjects: 27
Study 22632385 — intervention group
Group type: EXPERIMENTAL
Intervention: NDC + CBT (n = 10)
Number of subjects: 27
Study 22632385 — intervention group
Group type: COMPARATOR
Intervention: TAU (n = 8)
Number of subjects: 27
Study 22632385 — intervention group
Group type: EXPERIMENTAL
Intervention: MI + CBT
Number of subjects: 27
Study 22632385 — intervention group
Group type: EXPERIMENTAL
Intervention: NDC + CBT
Number of subjects: 27
Study 20096137 — intervention group
Group type: EXPERIMENTAL
Intervention: Montessori activities (personalised one‐to‐one interaction activities based on Montessori principles)
Number of subjects: 0
Study 20096137 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (conversation or reading from and looking at pictures in a newspaper)
Number of subjects: 0
Study 18570681 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT) in individual format (10 sessions)
Number of subjects: 204
Study 18570681 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT) in group format (10 sessions)
Number of subjects: 204
Study 18570681 — intervention group
Group type: COMPARATOR
Intervention: Standardized recommended treatment for somatization disorder in primary care (Smith's norms)
Number of subjects: 204
Study 17384957 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' perception of being involved in treatment
Number of subjects: 121
Study 17384957 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' feeling of being neglected by physicians
Number of subjects: 121
Study 17384957 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' perception of trust in physicians
Number of subjects: 121
Study 17384957 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived quality of psychosocial care
Number of subjects: 121
Study 15471826 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-FDG PET
Number of subjects: 55
Study 15471826 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary radiation
Number of subjects: 55
Study 15471826 — intervention group
Group type: EXPERIMENTAL
Intervention: SCC-Ag > or = 4 ng/mL
Number of subjects: 55
Study 15471826 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of symptoms at recurrence
Number of subjects: 55
Study 15471826 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk score system
Number of subjects: 55
Study 11302268 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive‐expressive therapy (SE)
Number of subjects: 308
Study 11302268 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 308
Study 11302268 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual drug counseling (IDC)
Number of subjects: 308
Study 9306425 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumpectomy without radiation
Number of subjects: 0
Study 9306425 — intervention group
Group type: COMPARATOR
Intervention: Lumpectomy with radiation
Number of subjects: 0
Study 8324036 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature biofeedback
Number of subjects: 39
Study 8324036 — intervention group
Group type: COMPARATOR
Intervention: Autogenic training
Number of subjects: 39
Study 3731566 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg administered three times daily
Number of subjects: 73
Study 3731566 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 240 mg daily
Number of subjects: 73
Study 31877418 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 90
Study 31877418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 31544330 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 0
Study 31544330 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 0
Study 29198193 — intervention group
Group type: EXPERIMENTAL
Intervention: High-lipid and high-phospholipid diet (HL-HP diet, containing 20 % lipid and 8 % PL)
Number of subjects: 12
Study 29198193 — intervention group
Group type: COMPARATOR
Intervention: High-lipid and low-phospholipid diet (HL-LP diet, containing 20 % lipid and 1.5 % PL)
Number of subjects: 12
Study 29198193 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphatidylcholine (PC) treatment in primary hepatocytes
Number of subjects: 12
Study 29198193 — intervention group
Group type: EXPERIMENTAL
Intervention: siRNA for CTP: choline phosphate cytidylyltranferase α (CCTα) treatment in primary hepatocytes
Number of subjects: 12
Study 25795256 — intervention group
Group type: EXPERIMENTAL
Intervention: MenABCWY formulation (full dose OMV)
Number of subjects: 484
Study 25795256 — intervention group
Group type: EXPERIMENTAL
Intervention: MenABCWY formulation (one-quarter dose OMV)
Number of subjects: 484
Study 25795256 — intervention group
Group type: COMPARATOR
Intervention: MenACWY-CRM (control)
Number of subjects: 484
Study 25795256 — intervention group
Group type: EXPERIMENTAL
Intervention: MenABCWY formulations
Number of subjects: 484
Study 24021044 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (TZP) 4.5 g, prolonged infusion every 6 hours for 3 hours
Number of subjects: 50
Study 24021044 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin/tazobactam (TZP) 4.5 g, regular infusion every 6 hours for 30 minutes
Number of subjects: 50
Study 21821328 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality navigation system
Number of subjects: 40
Study 21821328 — intervention group
Group type: COMPARATOR
Intervention: Freehand protocol
Number of subjects: 40
Study 19452245 — intervention group
Group type: COMPARATOR
Intervention: Conventional disease-modifying anti-rheumatic drugs (DMARDs)
Number of subjects: 145
Study 16794491 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 9995
Study 16794491 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 9995
Study 12738519 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (400 microg)
Number of subjects: 25
Study 12738519 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 11142581 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant alpha‐interferon 6 MU tiw plus ribavirin
Number of subjects: 100
Study 11142581 — intervention group
Group type: COMPARATOR
Intervention: recombinant alpha‐interferon 6 MU tiw
Number of subjects: 100
Study 9709273 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography and physical examination (MP)
Number of subjects: 50430
Study 9709273 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 50430
Study 8281731 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade 6 readability material
Number of subjects: 85
Study 8281731 — intervention group
Group type: COMPARATOR
Intervention: Grade 11 readability material
Number of subjects: 85
Study 8281731 — intervention group
Group type: COMPARATOR
Intervention: Grade 9 readability material
Number of subjects: 85
Study 3332805 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (average dose 0.4 mg/day)
Number of subjects: 10
Study 3332805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31582304 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthreshold nanosecond laser (SNL) treatment
Number of subjects: 292
Study 31582304 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 292
Study 30039159 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen (10 L per minute by nonrebreather facemask until delivery)
Number of subjects: 114
Study 30039159 — intervention group
Group type: COMPARATOR
Intervention: Room air (exposed to room air only without a facemask)
Number of subjects: 114
Study 30039159 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen
Number of subjects: 114
Study 30039159 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 114
Study 26115789 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmedicated ADHD patients
Number of subjects: 131
Study 26115789 — intervention group
Group type: EXPERIMENTAL
Intervention: Inattentive ADHD subtype
Number of subjects: 131
Study 26115789 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous stimulant medication history
Number of subjects: 131
Study 26115789 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 131
Study 24081374 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicyclol 25 mg three times daily
Number of subjects: 248
Study 24081374 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E (α-tocopherol) 100 mg three times daily
Number of subjects: 248
Study 22523379 — intervention group
Group type: EXPERIMENTAL
Intervention: Arctic Front® catheter
Number of subjects: 32
Study 22523379 — intervention group
Group type: COMPARATOR
Intervention: HD Mesh Ablator® catheter
Number of subjects: 32
Study 20933558 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum chewing
Number of subjects: 64
Study 20933558 — intervention group
Group type: COMPARATOR
Intervention: No gum chewing
Number of subjects: 64
Study 17629139 — intervention group
Group type: EXPERIMENTAL
Intervention: kinezitheraphy and functional electrical stimulation
Number of subjects: 40
Study 17629139 — intervention group
Group type: COMPARATOR
Intervention: kinezitheraphy
Number of subjects: 40
Study 16223964 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention with a depression care-manager offering algorithm-based care for MDD
Number of subjects: 324
Study 16223964 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 324
Study 11733660 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol-alfentanil
Number of subjects: 60
Study 11733660 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane-N2O
Number of subjects: 60
Study 11733660 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane-N2O
Number of subjects: 60
Study 9868184 — intervention group
Group type: EXPERIMENTAL
Intervention: Beef tallow (BT)
Number of subjects: 12
Study 9868184 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn oil (CO)
Number of subjects: 12
Study 9868184 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate (CHO)
Number of subjects: 12
Study 9868184 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fiber diet
Number of subjects: 12
Study 9868184 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fiber diet
Number of subjects: 12
Study 7846195 — intervention group
Group type: EXPERIMENTAL
Intervention: Milnacipran (100 mg/day)
Number of subjects: 190
Study 7846195 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 190
Study 3247517 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 19
Study 3247517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 3247517 — intervention group
Group type: EXPERIMENTAL
Intervention: Gated lung imaging
Number of subjects: 19
Study 27515095 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency neurotomy of the genicular nerves
Number of subjects: 73
Study 27515095 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular injection (2.5 mL of bupivacaine, 2.5 mg of morphine and 1 mL of betamethasone, 6 mL of fluid injection)
Number of subjects: 73
Study 26686847 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 μg daily for 12 weeks)
Number of subjects: 60
Study 26686847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 23264167 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine colostrum
Number of subjects: 9
Study 22710607 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib (150 mg/day p.o.) plus gemcitabine (1000 mg/m2, days 1, 8, 15, every 4 weeks)
Number of subjects: 17
Study 22710607 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine monotherapy
Number of subjects: 17
Study 20074372 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent screening and treatment (IST)
Number of subjects: 0
Study 20074372 — intervention group
Group type: COMPARATOR
Intervention: Intermittent preventive treatment (IPT)
Number of subjects: 0
Study 17573321 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 66
Study 17573321 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 66
Study 17573321 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 66